News | Radiopharmaceuticals and Tracers | September 11, 2015

Zevacor Installs First Medical-only 70 MeV Cyclotron in U.S.

Cyclone 70P to stabilize U.S. supply of Strontium 82, produce next generation of radiopharmaceutical products

Zevacor, IBA, 70 MeV cyclotron, Cyclone 70P, radiopharmaceuticals

September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

The 140-ton Cyclone 70P, manufactured in Belgium by Ion Beam Applications S.A (IBA), is the first commercial 70 MeV cyclotron dedicated to medical use in the United States. Expected to be fully operational in the first quarter of 2016, the cyclotron is being installed in a new, state-of-the-art high capacity manufacturing center. The center will house a complement of radioisotope synthesis equipment able to produce a broad range of radiopharmaceuticals for clinical and research applications.

The initial primary focus of the 70 MeV cyclotron will be the commercial manufacture of Strontium 82 to ensure an ample, stable U.S.-based supply of Strontium 82/Rubidium 82 generators for use in the diagnosis of cardiovascular disease. The cyclotron will also be employed to produce a wide variety of other radionuclides for both research and clinical applications.

The Cyclone 70P is an optimized, high-power proton cyclotron with variable proton acceleration in the energy range of 30 to 70 MeV. The 140-ton unit has two ports, six beam lines and capabilities for solid, liquid and gas targets.

For more information: www.iba-worldwide.com

Related Content

A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Cardiac Imaging | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of ...
SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram.

SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram. Results from an international study presented at #ACC19 show that pressure readings in coronary arteries may identify locations of stenoses remaining after cardiac cath interventions.

Feature | Cardiac Imaging | March 18, 2019 | By Greg Freiherr
As many as one in four patients who undergo cath lab interventions can benefit from a technology that identifies the
Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Feature | Cardiac Imaging | March 17, 2019 | By Greg Freiherr
Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applica
WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography.

WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography. Photo by Greg Freiherr

Feature | Cardiac Imaging | March 16, 2019 | By Greg Freiherr
Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in echoca
Podcast | Cardiac Imaging | March 15, 2019
Debate About Coronary Testing Highlights ACC Session

Collage depicts broad applications in machine learning or deep learning (DL) that can be applied to advanced medical imaging technologies. Size of the liver and its fat fraction — 22 percent — (top middle in collage) can be quantified automatically using an algorithm developed by Dr. Albert Hsiao and his team at the University of California San Diego. This and other information that might be mined by DL algorithms from CT and MR images could help personalize patients’ treatment. Collage provided by Albert Hsiao

Feature | Cardiac Imaging | March 12, 2019 | By Greg Freiherr
Acquiring these data could change patient management
Podcast | Cardiac Imaging | March 12, 2019
How smart algorithms might reduce the burden of modern practice
Podcast | Cardiac Imaging | March 08, 2019
Why CT angiography cannot replace invasive angiography
Podcast | Cardiac Imaging | March 04, 2019
AI, Mobile Technologies Are Changing How We Think About Cardiac Disease
Overlay Init